ANEB
Anebulo Pharmaceuticals
ANEB
ANEB
Delisted
ANEB was delisted on the 27th of February, 2026.
11 hedge funds and large institutions have $19.2M invested in Anebulo Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
11
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$6.05M | |
| 2 | +$1.82M | |
| 3 | +$2.13K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$671 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$60 |
Top Sellers
| 1 | -$88.9K | |
| 2 | -$88.8K | |
| 3 | -$710 | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$455 |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$50 |